T. Anders Olsen

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Vadim S. Koshkin, Nicholas Henderson, Marihella James et al. · Cancer · 2021 · 85 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

Dylan J. Martini, Subir Goyal, Yuan Liu et al. · The Oncologist · 2021 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

Dylan J. Martini, T. Anders Olsen, Subir Goyal et al. · Frontiers in Oncology · 2021 · 36 citations · Full text

Medicine, Oncology, Radiology +17

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

Dylan J. Martini, Julie M. Shabto, Subir Goyal et al. · The Oncologist · 2021 · 32 citations · Full text

Medicine, Immunology, Oncology +17

The Cost of Metastatic Prostate Cancer in the United States

T. Anders Olsen, Christopher P. Filson, Thomas B. Richards et al. · Urology Practice · 2022 · 21 citations

Medicine, Oncology, Health Economics +16